AMPlify is an established platform designed to advance Finnish healthcare companies' US market readiness and entry. Expanding upon the successful Nordic AMPlify and Gazelle programs, AMPlify is a complete ecosystem that brings Finnish companies and Mayo Clinic together.
The US market represents 40% of the global healthcare market, and more than 30% of new technologies are joint ventures with non-US entities. American health systems are transforming their innovation centers into international co-development ventures. AMPlify is leading this transition and Mayo Clinic has selected Finland as a strategy focus area.
Mayo Clinic, one of the leading health systems globally, constantly seeks to provide its patients the best and most efficient care. They recognize that this can only be accomplished through constant innovation across the entire continuum of care. Hence, there is a need to find the best ways to improve care, reduce costs, and improve the quality of life for all patients.
Co-development is key to essential, and working with new companies and ideas is a proven pathway. The need for more and better digital tools is real and visible. Now is the time to focus resources on US entry through AMPlify with local champions. AMPlify is a strategic and competitive advantage.
AMP is a carefully thought out and curated program consisting of workshops, one-on-one mentoring, and webinars with leading US healthcare players including providers, VCs, strategics, and Mayo Clinic experts. Participating companies will receive feedback, help with the value proposition and focus, and access to KOLs while gaining market and business insight. All aspects of commercial and clinical success will be covered.
AMPlify 2025 will accommodate 10–12 selected companies, offering a structured pathway to accelerate U.S. market entry.